pxt00864
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2013 (NCT02361424)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pxt00864
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02361242 | Phase 2 | Jun 1, 2013 | Ascopharm Groupe Novasco, Pharnext SA, University of Bordeaux |
| NCT02361424 | Phase 2 | Feb 1, 2013 | Ascopharm Groupe Novasco, Pharnext SA, University of Bordeaux |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ascopharm Groupe Novasco | For profit | 2 | 0 | 1 | 2013 |
| Pharnext SA | For profit | 2 | 2 | 1 | 2013 |
| University of Bordeaux | Academic/Hospital | 2 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1